Background/Aims: Globus is a persistent or intermittent non-painful sensation of a lump or foreign body in the throat and a commonly encountered clinical condition. We aim to evaluate the prevalence of gastroesophageal reflux disease (GERD) and to determine the parameters for predicting the response to treatment with proton pump inhibitor (PPI) using wireless pH monitoring in patients with globus sense. Methods: We retrospectively reviewed the medical records of 37 patients with atypical GERD symptoms. A total of 27 patients with dominant globus sense were enrolled. Endoscopic examination and 48-hour wireless esophageal pH monitoring were performed, and the patients underwent a therapeutic trial of full dose PPIs daily over a period of 4 weeks. Results: Both typical and atypical GERD symptoms co-existed in 14 patients (51.9%, 14/27). According to ROME III criteria, 19 patients (70.4%, 19/27) were diagnosed as GERD. Twelve patients (44.4%, 12/27) were PPI responders. A significant difference in the frequency of symptom index (＋) or symptom associated probability (＋) was observed between the PPI responder group and the non-responder group (p＜0.01). Conclusions: In patients with globus sense, 70.4% were diagnosed with GERD. Symptom index/symptom associated probability in wireless ambulatory pH monitoring was a good objective parameter for PPI responder. (Korean J Gastroenterol 2015;65:85-89) 
INTRODUCTION
Globus is a persistent or intermittent non-painful sensation of a lump or foreign body in the throat and a commonly encountered clinical condition. The etiology of globus appears to be multifactorial; gastroesophageal reflux disease (GERD), abnormalities of the upper esophageal sphincter, psychological disorder, structural head and neck disease, cervical heterotopic gastric mucosa, and Helicobacter pylori infection. Although data are conflicting, GERD had been suggested to be a major etiology of this symptom, potentially accounting for 23-68% of globus patients. 1 Modalities used to establish the diagnosis of esophageal disease include upper endoscopy, esophageal manometry, ambulatory esophageal pH monitoring and an empirical trial with high-dose proton pump inhibitor (PPI). Due to the low prevalence of esophageal mucosal findings, upper endoscopy has been suggested to have limited value in globus symptoms. 2, 3 Ambulatory pH monitoring is particularly helpful for detection of GERD in patients who underwent normal endoscopy and failed to respond to a therapeutic trial with PPI. 4 However, in review of the literature, extraesophageal GERD symptoms improve more slowly than esophageal GERD symptoms following acid-suppressive therapy. 5 To the best of our knowledge, data available for evaluation of the relationship between globus sensation and PPI treatment guided by objective parameters are limited. Parameters implicating GERD as the etiology of globus could be more helpful in predicting the response to anti-reflux therapy. The aims of the study were to evaluate the prevalence of GERD and the effectiveness of empirical treatment with PPI in patients with globus sensation and to determine the parameters for predicting the response to PPI. were assessed by careful history taking.
SUBJECTS AND METHODS

Study population
The most common chief laryngeal complaints were globus (27), followed by throat discomfort or sore throat (10), chest pain (5) and hoarseness of voice (4) . Globus was the dominant atypical GERD symptom, and a total of 27 patients were enrolled in this study. All patients underwent a therapeutic tri- Review Board (VC14 RISI0023).
Endoscopy and 48-hour wireless ambulatory pH monitoring
Forty-eight hour ambulatory esophageal pH monitoring was performed using the wireless pH capsule system (BRAVO pH System; Medtronic Inc., Shoreview, MN, USA) during at least 14 days off-PPI. All patients underwent endoscopy within 2 months before pH monitoring. The probe was placed at 5 cm from the squamo-columnar junction, after transoral introduction using a standard placement technique. Data were analyzed separately for each 24-hour period and the worst day was used for diagnosis.
Definition of GERD and parameter
GERD was classified as 1) erosive reflux disease (ERD); 2)
pH＋ non-erosive reflux disease (NERD) with normal endoscopy and pathologic acid exposure; and (3) hypersensitive esophagus with normal endoscopy, normal distal esophageal acid exposure, and positive symptom association for acid reflux by ROME III criteria. 6 Total 24-hour esophageal acid exposure (%) was defined as the total time at pH below 4 divided by time of monitoring. Total distal esophageal acid exposure less than 4.2% over 24 hours was considered normal. Symptom index (SI) was defined as the number of symptoms associated with reflux divided by the total number of symptoms. Symptom associated probability (SAP) was calculated as the probability that the observed distribution could occur by chance. SI and SAP were considered positive at ≥50% and ≥95%, respectively.
Statistical methods
Data are shown in a descriptive manner; median (interquartile range) and number (percentage). Results in the GERD and non-GERD groups were compared using the Mann Whitney U-test. Fisher's exact test was used to determine differences between PPI response group and PPI non-response group. A p-value ＜0.05 was considered statistically significant.
RESULTS
The patients consisted of 15 men (55.6%) and 12 women 
DISCUSSION
To date, the effect of PPI in chronic laryngitis has been inconclusive. When the study was applied to patients with atypical symptoms, PPI therapy resulted in complete symptom resolution in 69% of the participants, 12% of the patients showed improvement of symptoms, and 20% showed minimal or no improvement. 7 On the contrary, placebo-controlled trials and meta-analyses have failed to demonstrate any therapeutic benefit of PPIs. 8, 9 We thought that these conflicting data resulted from the non-uniformity of patients enrolled in previous studies. Laryngopharyngeal reflux (LPR) is a heterogenous disorder with a wide spectrum of symptoms including throat discomfort, hoarseness of voice, cough, throat clearing and globus sensation. In addition, atypical manifestation of GERD shows different treatment response according to each symptom. In a previous study, hoarseness and throat clearing improved significantly, while throat pain, difficulty swallowing, and globus showed the same response in both treatment arms and placebo arms. 10 In our result, prevalence of GERD was 70.4% of patients with globus and treatment response was 44.4%, which is a higher prevalence of GERD and a lower rate of treatment response compared with the published studies. It was noteworthy that the patients enrolled in this study had a dominant symptom of globus sense among laryngopharyngeal symptoms, so that our study had relative homogeneity.
In patients with laryngopharyngeal symptoms significant improvement is known to occur more slowly compared to those with esophageal symptoms following acid suppression therapy. It is widely accepted that extraesophageal GERD symptoms require more aggressive and prolonged therapy than typical GERD symptom. 5, 11, 12 The precise pathophysiology of globus remains unclear. Several mechanisms have been proposed to explain the association between GERD and the globus sensation in previous reports: 1) direct irritation and inflammation of the laryngopharynx by gastric acid; 2) elevated UES pressure triggered by gastroesophageal reflux; acidification or distention of the distal esophagus. 1, 13, 14 Thus, the incidence of heart burn or regurgitation in combination with a globus sensation might be much higher. In this study, we found that weak heartburn or regurgitation was more common in the GERD group than in the non-GERD group. The presence of classical reflux symptoms might be a risk factor for predicting GERD in patients with globus. There were potential limitations of this study. First, due to the retrospective data, we could not account for all of the factors (e.g., smoking, alcohol, obesity) involved in symptom production of globus. However, in review of data from previous studies, there was no definite association with smoking, alcohol, or body mass index in globus sensation. 4 Second, atypical reflux symptoms usually persist continuously. It is difficult for patients to mark a reflux event. 17 In this study, we asked the patients to mark the time when they perceived aggravation of symptoms during pH monitoring. The symptom index was regarded as positive if an event was marked within 5 minutes after the onset of a reflux episode, and we tried to overcome the limitation.
To the best of our knowledge, this is the first study to investigate objective parameters for prediction of treatment response of PPI in patients with globus symptoms by means of 48-hour ambulatory pH monitoring and endoscopy. Our study showed that esophageal pH monitoring could discriminate patients as PPI responder and non-responder, and that symptom-reflux association could be a good predictor of PPI response in patients with globus.
In conclusion, SI/SAP in 48-hour ambulatory pH monitoring is a good objective parameter for positive PPI response in patients who present with globus symptoms. By exclusion of all other factors, along with pH monitoring, patients with globus will benefit from potent and prolonged PPI therapy.
